Literature DB >> 7986307

The contribution of lipids to coronary heart disease in diabetes mellitus.

M W Stewart1, M F Laker, K G Alberti.   

Abstract

Cardiovascular disease is two to three times more common in diabetic patients than in the non-diabetic population. Although risk factors that affect the general population such as age, cigarette smoking, hypertension, obesity and hypercholesterolaemia also affect diabetic subjects, the increased prevalence of hypertension and obesity in non-insulin-dependent diabetes mellitus (NIDDM) only partially explains the increased morbidity and mortality from coronary heart disease (CHD). Other factors must therefore be considered in this group of patients. Triglyceride concentrations, particularly post-prandial levels, may be important. Diabetic subjects have increased very-low-density-lipoprotein (VLDL), increased intermediate-density-lipoprotein (IDL) and low high-density-lipoprotein (HDL) concentrations, and differences in lipoprotein composition may partly explain increased atherogenesis. Although LDL levels of diabetic patients are not different from those of control subjects. LDL particles are potentially atherogenic as they are smaller, more dense and prone to oxidative modification. NIDDM subjects also have altered apolipoprotein concentrations, including increased apoB, apoC-III, and decreased apoA-I; in addition, apoE-2 may be over-represented in diabetic populations. Thus, apart from the traditional risk factors, there are several lipoprotein compositional abnormalities that may contribute to the increased prevalence of CHD in diabetes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986307

Source DB:  PubMed          Journal:  J Intern Med Suppl        ISSN: 0955-7873


  7 in total

1.  ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.

Authors:  Guozhi Xiao; Ting Zhang; Shibing Yu; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Steven Ringquist; H Henry Dong
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

2.  The importance of obesity and hyperlipidaemia in patients with renal transplants.

Authors:  L Locsey; L Asztalos; Z Kincses; C Berczi; G Paragh
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

3.  FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Ann Piccirillo; Yong Fan; Radha Uppala; Eric Goetzman; H Henry Dong
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

Review 4.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

5.  Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.

Authors:  Yun-Zi Liu; Xiaoyun Cheng; Ting Zhang; Sojin Lee; Jun Yamauchi; Xiangwei Xiao; George Gittes; Shen Qu; Chun-Lei Jiang; H Henry Dong
Journal:  J Biol Chem       Date:  2016-05-11       Impact factor: 5.157

6.  Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes.

Authors:  Lisa Juntti-Berggren; Essam Refai; Ioulia Appelskog; Mats Andersson; Gabriela Imreh; Nancy Dekki; Sabine Uhles; Lina Yu; William J Griffiths; Sergei Zaitsev; Ingo Leibiger; Shao-Nian Yang; Gunilla Olivecrona; Hans Jörnvall; Per-Olof Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 7.  Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle.

Authors:  Ismael Valladolid-Acebes; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.